A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma. uri icon

authors

  • Dasyam, Nathaniel
  • Ostapowicz, Tess
  • Kumar, Rajiv
  • Lowe, Jessica
  • Maxwell, Alice
  • Burn, Olivia K
  • Williams, Geoffrey M
  • Carley, Sarah E
  • Caygill, Graham
  • Jones, Jeremy
  • Chan, Susanna T S
  • Sharples, Katrina J
  • Hinder, Victoria A
  • Macapagal, Jerome
  • McCusker, Monica
  • Weinkove, Robert
  • Brimble, Margaret A
  • Painter, Gavin F
  • Findlay, Michael P
  • Dunbar, P Rod
  • Gasser, Olivier
  • Hermans, Ian F
  • Barrow, Catherine
  • Huang, Ying
  • Bauer, Evelyn
  • Mester, Brigitta
  • Wood, Catherine E
  • Authier-Hall, Astrid
  • Dzhelali, Marina

publication date

  • January 1, 2023